PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver disease. - Chalasani N; Vilar-Gomez E; Loomba R; Yates KP; Diehl AM; Neuschwander-Tetri BA; Dasarathy S; Kowdley KV; Terrault N; Wilson LA; Tonascia J; Sanyal AJ (Hepatology (Baltimore, Md.), 2024)